Pricing Log in Create free account

Inventiva S.A. Sponsored ADR (IVA) vs Syndax Pharmaceuticals, Inc. (SNDX)

Inventiva S.A. Sponsored ADR and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Inventiva S.A. Sponsored ADR and Syndax Pharmaceuticals, Inc. are of similar size ($867.9M and $843.6M). Inventiva S.A. Sponsored ADR grew revenue faster over the last twelve months: 547.9% against 159.5%. Syndax Pharmaceuticals, Inc. has the higher net margin (−72.4% vs −750.3%) and the lower return on invested capital (−83.4% vs 0.00%). Across the 17 metrics below, Syndax Pharmaceuticals, Inc. leads on 9 and Inventiva S.A. Sponsored ADR on 8.

Valuation

Metric IVA SNDX Biotechnology median
P/E n/m n/m 10.60
P/S 7.43 2.96 9.40
P/B 2.13 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.54 3.56 9.02
Earnings yield (94.51%) (24.74%) (32.88%)
Free cash flow yield (94.32%) (20.73%) (23.13%)

Profitability

Metric IVA SNDX Biotechnology median
Gross margin 0.00% 92.21% 68.51%
Operating margin 0.00% (61.72%) 0.00%
Net margin (750.28%) (72.38%) 0.00%
Free cash flow margin 0.00% (61.36%) 0.00%
Return on equity 0.00% (426.43%) (51.96%)
Return on assets 0.00% (33.67%) (46.06%)
Return on invested capital 0.00% (83.42%) 0.00%

Growth

Metric IVA SNDX Biotechnology median
Revenue growth (TTM) 547.89% 159.46% 6.76%
EPS growth (last fiscal year) 35.44% 11.56% 29.88%
Revenue growth, 5-year CAGR 8.33% 157.68% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IVA SNDX Biotechnology median
Debt to equity 1.13 (34.24) 0.00
Current ratio 3.81 4.69 4.97
Net debt to EBITDA 0.29 0.25 1.01

Dividend

Metric IVA SNDX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IVA SNDX Biotechnology median
Market cap 867.93m 843.57m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack